APO Research, Inc.

APO RESEARCH · REPORT

Calcitonin Injection

Selected research

Industry Growth & Trends

Global Calcitonin Injection Industry Growth and Trends Forecast to 2032

Market perspective

The global Calcitonin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Calcitonin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Calcitonin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Calcitonin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Calcitonin Injection include Yingu, Shanghai No.1 Bio, Qingdao Guoda, Novartis, Guilin Pharma, Chengdu List Pharma, Lisapharma, Hybio Pharmaceutical and Guoda Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Calcitonin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Calcitonin Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Calcitonin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Calcitonin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Calcitonin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Calcitonin Injection Market by Company

Yingu

Shanghai No.1 Bio

Qingdao Guoda

Novartis

Guilin Pharma

Chengdu List Pharma

Lisapharma

Hybio Pharmaceutical

Guoda Bio

Future Health Pharma

DAPHAE

CSPC

Asahi Kasei Pharma

Calcitonin Injection Segment by Type

Elcatonin Injection

Salmon Calcitonin Injection

Calcitonin Injection Segment by Application

Hospital

Clinic

Calcitonin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcitonin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calcitonin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcitonin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Calcitonin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Calcitonin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Elcatonin Injection Table 2. Major Company of Salmon Calcitonin Injection Table 3. Global Calcitonin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Calcitonin Injection Sales by Type (2021-2026) & (k units) Table 5. Global Calcitonin Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Calcitonin Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Calcitonin Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Calcitonin Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Calcitonin Injection Sales by Type (2027-2032) & (k units) Table 10. Global Calcitonin Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Calcitonin Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Calcitonin Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Calcitonin Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Calcitonin Injection Sales by Type (2021-2026) & (k units) Table 15. North America Calcitonin Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Calcitonin Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Calcitonin Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Calcitonin Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Calcitonin Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Calcitonin Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Calcitonin Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Calcitonin Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Calcitonin Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Calcitonin Injection Industry Trends Table 25. Calcitonin Injection Industry Drivers Table 26. Calcitonin Injection Industry Opportunities and Challenges Table 27. Calcitonin Injection Industry Restraints Table 28. Global Calcitonin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Calcitonin Injection Revenue Market Share by Company (2021-2026) Table 30. Global Calcitonin Injection Sales by Company (2021-2026) & (k units) Table 31. Global Calcitonin Injection Sales Share by Company (2021-2026) Table 32. Global Calcitonin Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Calcitonin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Calcitonin Injection Major Company Production Sites and Headquarters Table 35. Global Calcitonin Injection Company, Product Type & Application Table 36. Global Calcitonin Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Calcitonin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Calcitonin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Calcitonin Injection Sales by Region (2021-2026) & (k units) Table 41. Global Calcitonin Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Calcitonin Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Calcitonin Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Calcitonin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Calcitonin Injection Sales by Region (2027-2032) & (k units) Table 46. Global Calcitonin Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Calcitonin Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Calcitonin Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Calcitonin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Calcitonin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Calcitonin Injection Sales by Application (2021-2026) & (k units) Table 52. Global Calcitonin Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Calcitonin Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Calcitonin Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Calcitonin Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Calcitonin Injection Sales by Application (2027-2032) & (k units) Table 57. Global Calcitonin Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Calcitonin Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Calcitonin Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Calcitonin Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Calcitonin Injection Sales by Application (2021-2026) & (k units) Table 62. North America Calcitonin Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Calcitonin Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Calcitonin Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Calcitonin Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Calcitonin Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Calcitonin Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Calcitonin Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Calcitonin Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Calcitonin Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Yingu Company Information Table 72. Yingu Business Overview Table 73. Yingu Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Yingu Calcitonin Injection Product Portfolio Table 75. Yingu Recent Development Table 76. Shanghai No.1 Bio Company Information Table 77. Shanghai No.1 Bio Business Overview Table 78. Shanghai No.1 Bio Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Shanghai No.1 Bio Calcitonin Injection Product Portfolio Table 80. Shanghai No.1 Bio Recent Development Table 81. Qingdao Guoda Company Information Table 82. Qingdao Guoda Business Overview Table 83. Qingdao Guoda Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Qingdao Guoda Calcitonin Injection Product Portfolio Table 85. Qingdao Guoda Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Novartis Calcitonin Injection Product Portfolio Table 90. Novartis Recent Development Table 91. Guilin Pharma Company Information Table 92. Guilin Pharma Business Overview Table 93. Guilin Pharma Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Guilin Pharma Calcitonin Injection Product Portfolio Table 95. Guilin Pharma Recent Development Table 96. Chengdu List Pharma Company Information Table 97. Chengdu List Pharma Business Overview Table 98. Chengdu List Pharma Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Chengdu List Pharma Calcitonin Injection Product Portfolio Table 100. Chengdu List Pharma Recent Development Table 101. Lisapharma Company Information Table 102. Lisapharma Business Overview Table 103. Lisapharma Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Lisapharma Calcitonin Injection Product Portfolio Table 105. Lisapharma Recent Development Table 106. Hybio Pharmaceutical Company Information Table 107. Hybio Pharmaceutical Business Overview Table 108. Hybio Pharmaceutical Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Hybio Pharmaceutical Calcitonin Injection Product Portfolio Table 110. Hybio Pharmaceutical Recent Development Table 111. Guoda Bio Company Information Table 112. Guoda Bio Business Overview Table 113. Guoda Bio Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Guoda Bio Calcitonin Injection Product Portfolio Table 115. Guoda Bio Recent Development Table 116. Future Health Pharma Company Information Table 117. Future Health Pharma Business Overview Table 118. Future Health Pharma Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Future Health Pharma Calcitonin Injection Product Portfolio Table 120. Future Health Pharma Recent Development Table 121. DAPHAE Company Information Table 122. DAPHAE Business Overview Table 123. DAPHAE Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. DAPHAE Calcitonin Injection Product Portfolio Table 125. DAPHAE Recent Development Table 126. CSPC Company Information Table 127. CSPC Business Overview Table 128. CSPC Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. CSPC Calcitonin Injection Product Portfolio Table 130. CSPC Recent Development Table 131. Asahi Kasei Pharma Company Information Table 132. Asahi Kasei Pharma Business Overview Table 133. Asahi Kasei Pharma Calcitonin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Asahi Kasei Pharma Calcitonin Injection Product Portfolio Table 135. Asahi Kasei Pharma Recent Development Table 136. North America Calcitonin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Calcitonin Injection Sales by Country (2021-2026) & (k units) Table 138. North America Calcitonin Injection Sales Market Share by Country (2021-2026) Table 139. North America Calcitonin Injection Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Calcitonin Injection Sales Market Share Forecast by Country (2027-2032) Table 141. North America Calcitonin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Calcitonin Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Calcitonin Injection Market Share by Country (2021-2026) Table 144. North America Calcitonin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Calcitonin Injection Market Share Forecast by Country (2027-2032) Table 146. Europe Calcitonin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Calcitonin Injection Sales by Country (2021-2026) & (k units) Table 148. Europe Calcitonin Injection Sales Market Share by Country (2021-2026) Table 149. Europe Calcitonin Injection Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Calcitonin Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Calcitonin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Calcitonin Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Calcitonin Injection Market Share by Country (2021-2026) Table 154. Europe Calcitonin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Calcitonin Injection Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Calcitonin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Calcitonin Injection Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Calcitonin Injection Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Calcitonin Injection Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Calcitonin Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Calcitonin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Calcitonin Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Calcitonin Injection Market Share by Country (2021-2026) Table 164. Asia-Pacific Calcitonin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Calcitonin Injection Market Share Forecast by Country (2027-2032) Table 166. Latin America Calcitonin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Calcitonin Injection Sales by Country (2021-2026) & (k units) Table 168. Latin America Calcitonin Injection Sales Market Share by Country (2021-2026) Table 169. Latin America Calcitonin Injection Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Calcitonin Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Calcitonin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Calcitonin Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Calcitonin Injection Market Share by Country (2021-2026) Table 174. Latin America Calcitonin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Calcitonin Injection Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Calcitonin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Calcitonin Injection Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Calcitonin Injection Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Calcitonin Injection Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Calcitonin Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Calcitonin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Calcitonin Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Calcitonin Injection Market Share by Country (2021-2026) Table 184. Middle East and Africa Calcitonin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Calcitonin Injection Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Calcitonin Injection Distributors List Table 189. Calcitonin Injection Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Calcitonin Injection Image Figure 2. Global Calcitonin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Calcitonin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Calcitonin Injection Sales (2021-2032) & (k units) Figure 5. Elcatonin Injection Image Figure 6. Global Elcatonin Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Salmon Calcitonin Injection Image Figure 8. Global Salmon Calcitonin Injection Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Calcitonin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Calcitonin Injection Market Share by Type 2025 VS 2032 Figure 11. North America Calcitonin Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Calcitonin Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Calcitonin Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Calcitonin Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Calcitonin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Calcitonin Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Calcitonin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Calcitonin Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Calcitonin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Calcitonin Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Calcitonin Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Calcitonin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Calcitonin Injection Market Share by Application 2025 VS 2032 Figure 29. North America Calcitonin Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Calcitonin Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Calcitonin Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Calcitonin Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Calcitonin Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Calcitonin Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Calcitonin Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Calcitonin Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Calcitonin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Calcitonin Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Calcitonin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Calcitonin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Calcitonin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Calcitonin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Calcitonin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Calcitonin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Calcitonin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Calcitonin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Calcitonin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Calcitonin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Calcitonin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Calcitonin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Calcitonin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Calcitonin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Calcitonin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Calcitonin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Calcitonin Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Calcitonin Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Elcatonin Injection
  • Salmon Calcitonin Injection
Applications
  • Hospital
  • Clinic
Companies covered
  • Yingu
  • Shanghai No.1 Bio
  • Qingdao Guoda
  • Novartis
  • Guilin Pharma
  • Chengdu List Pharma
  • Lisapharma
  • Hybio Pharmaceutical
  • Guoda Bio
  • Future Health Pharma
  • DAPHAE
  • CSPC
  • Asahi Kasei Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Calcitonin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Calcitonin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Calcitonin Injection Market by Type
  6. 1.3.1 Elcatonin Injection
  7. 1.3.2 Salmon Calcitonin Injection
  8. 1.4 Global Calcitonin Injection Market Size by Type
  9. 1.4.1 Global Calcitonin Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Calcitonin Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Calcitonin Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Calcitonin Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Calcitonin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Calcitonin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Calcitonin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Calcitonin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Calcitonin Injection Industry Trends
  2. 2.2 Calcitonin Injection Industry Drivers
  3. 2.3 Calcitonin Injection Industry Opportunities and Challenges
  4. 2.4 Calcitonin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Calcitonin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Calcitonin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Calcitonin Injection Price (2021-2026)
  4. 3.4 Global Calcitonin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Calcitonin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Calcitonin Injection Company, Product Type & Application
  7. 3.7 Global Calcitonin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Calcitonin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Calcitonin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Calcitonin Injection Tier 1, Tier 2, and Tier 3
4 Calcitonin Injection Regional Status and Outlook
  1. 4.1 Global Calcitonin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Calcitonin Injection Historic Market Size by Region
  3. 4.2.1 Global Calcitonin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Calcitonin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Calcitonin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Calcitonin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Calcitonin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Calcitonin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Calcitonin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Calcitonin Injection by Application
  1. 5.1 Calcitonin Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Calcitonin Injection Market Size by Application
  5. 5.2.1 Global Calcitonin Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Calcitonin Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Calcitonin Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Calcitonin Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Calcitonin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Calcitonin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Calcitonin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Calcitonin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yingu
  2. 6.1.1 Yingu Company Information
  3. 6.1.2 Yingu Business Overview
  4. 6.1.3 Yingu Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yingu Calcitonin Injection Product Portfolio
  6. 6.1.5 Yingu Recent Developments
  7. 6.2 Shanghai No.1 Bio
  8. 6.2.1 Shanghai No.1 Bio Company Information
  9. 6.2.2 Shanghai No.1 Bio Business Overview
  10. 6.2.3 Shanghai No.1 Bio Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai No.1 Bio Calcitonin Injection Product Portfolio
  12. 6.2.5 Shanghai No.1 Bio Recent Developments
  13. 6.3 Qingdao Guoda
  14. 6.3.1 Qingdao Guoda Company Information
  15. 6.3.2 Qingdao Guoda Business Overview
  16. 6.3.3 Qingdao Guoda Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qingdao Guoda Calcitonin Injection Product Portfolio
  18. 6.3.5 Qingdao Guoda Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Calcitonin Injection Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Guilin Pharma
  26. 6.5.1 Guilin Pharma Company Information
  27. 6.5.2 Guilin Pharma Business Overview
  28. 6.5.3 Guilin Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guilin Pharma Calcitonin Injection Product Portfolio
  30. 6.5.5 Guilin Pharma Recent Developments
  31. 6.6 Chengdu List Pharma
  32. 6.6.1 Chengdu List Pharma Company Information
  33. 6.6.2 Chengdu List Pharma Business Overview
  34. 6.6.3 Chengdu List Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Chengdu List Pharma Calcitonin Injection Product Portfolio
  36. 6.6.5 Chengdu List Pharma Recent Developments
  37. 6.7 Lisapharma
  38. 6.7.1 Lisapharma Company Information
  39. 6.7.2 Lisapharma Business Overview
  40. 6.7.3 Lisapharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lisapharma Calcitonin Injection Product Portfolio
  42. 6.7.5 Lisapharma Recent Developments
  43. 6.8 Hybio Pharmaceutical
  44. 6.8.1 Hybio Pharmaceutical Company Information
  45. 6.8.2 Hybio Pharmaceutical Business Overview
  46. 6.8.3 Hybio Pharmaceutical Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hybio Pharmaceutical Calcitonin Injection Product Portfolio
  48. 6.8.5 Hybio Pharmaceutical Recent Developments
  49. 6.9 Guoda Bio
  50. 6.9.1 Guoda Bio Company Information
  51. 6.9.2 Guoda Bio Business Overview
  52. 6.9.3 Guoda Bio Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Guoda Bio Calcitonin Injection Product Portfolio
  54. 6.9.5 Guoda Bio Recent Developments
  55. 6.10 Future Health Pharma
  56. 6.10.1 Future Health Pharma Company Information
  57. 6.10.2 Future Health Pharma Business Overview
  58. 6.10.3 Future Health Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Future Health Pharma Calcitonin Injection Product Portfolio
  60. 6.10.5 Future Health Pharma Recent Developments
  61. 6.11 DAPHAE
  62. 6.11.1 DAPHAE Company Information
  63. 6.11.2 DAPHAE Business Overview
  64. 6.11.3 DAPHAE Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 DAPHAE Calcitonin Injection Product Portfolio
  66. 6.11.5 DAPHAE Recent Developments
  67. 6.12 CSPC
  68. 6.12.1 CSPC Company Information
  69. 6.12.2 CSPC Business Overview
  70. 6.12.3 CSPC Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSPC Calcitonin Injection Product Portfolio
  72. 6.12.5 CSPC Recent Developments
  73. 6.13 Asahi Kasei Pharma
  74. 6.13.1 Asahi Kasei Pharma Company Information
  75. 6.13.2 Asahi Kasei Pharma Business Overview
  76. 6.13.3 Asahi Kasei Pharma Calcitonin Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Asahi Kasei Pharma Calcitonin Injection Product Portfolio
  78. 6.13.5 Asahi Kasei Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Calcitonin Injection Sales by Country
  2. 7.1.1 North America Calcitonin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Calcitonin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Calcitonin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Calcitonin Injection Market Size by Country
  6. 7.2.1 North America Calcitonin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Calcitonin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Calcitonin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Calcitonin Injection Sales by Country
  2. 8.1.1 Europe Calcitonin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Calcitonin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Calcitonin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Calcitonin Injection Market Size by Country
  6. 8.2.1 Europe Calcitonin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Calcitonin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Calcitonin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Calcitonin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Calcitonin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Calcitonin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Calcitonin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Calcitonin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Calcitonin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Calcitonin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Calcitonin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Calcitonin Injection Sales by Country
  2. 10.1.1 South America Calcitonin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Calcitonin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Calcitonin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Calcitonin Injection Market Size by Country
  6. 10.2.1 South America Calcitonin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Calcitonin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Calcitonin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Calcitonin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Calcitonin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Calcitonin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Calcitonin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Calcitonin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Calcitonin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Calcitonin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Calcitonin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Calcitonin Injection Value Chain Analysis
  2. 12.1.1 Calcitonin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Calcitonin Injection Production Mode & Process
  7. 12.2 Calcitonin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Calcitonin Injection Distributors
  10. 12.2.3 Calcitonin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.